Michael Hinchcliffe
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Amyotrophic Lateral Sclerosis Research
Papers in
-
- Advanced Drug Delivery Systems 4
-
- Protein purification and stability 1
- Co-authors
- Lisbeth Illum (3 shared papers)Alan M. Smith (3 shared papers)Alan Smith (1 shared paper)Michael Perelman (1 shared paper)Inderjit Jabbal‐Gill (3 shared papers)Peter Watts (2 shared papers)Abraham R. Tzafriri (1 shared paper)H. Parnas (1 shared paper)
- Journals
- Influenza and Other Respiratory Viruses (1 paper)Clinical Cancer Research (1 paper)Pharmaceutics (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- United KingdomNorwayItaly
In The Last Decade
Michael Hinchcliffe
12 papers receiving 565 citations
Peers
Comparison fields: 5 of 94
- Pharmaceutical Science 241
- Neurology 63
- Immunology 87
- Biomaterials 52
- Microbiology 21
Countries citing papers authored by Michael Hinchcliffe
This map shows the geographic impact of Michael Hinchcliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hinchcliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hinchcliffe more than expected).
Fields of papers citing papers by Michael Hinchcliffe
This network shows the impact of papers produced by Michael Hinchcliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hinchcliffe. The network helps show where Michael Hinchcliffe may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Hinchcliffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 137 | |
| 2 | 2013 | 115 | |
| 3 | 2017 | 76 | |
| 4 | 2005 | 48 | |
| 5 | 2005 | 40 | |
| 6 | 1996 | 39 | |
| 7 | 2012 | 32 | |
| 8 | 2014 | 28 | |
| 9 | 2005 | 27 | |
| 10 | 2019 | 23 | |
| 11 | 2020 | 20 | |
| 12 | Characterisation of Bond Line Porosity | 2008 | 4 |
About Michael Hinchcliffe
Michael Hinchcliffe is a scholar working on Pharmaceutical Science, Molecular Biology, Epidemiology, Infectious Diseases and Genetics, having authored 12 papers that have together received 589 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (4 papers), Influenza Virus Research Studies (3 papers), Respiratory viral infections research (2 papers), Viral gastroenteritis research and epidemiology (2 papers), Amyotrophic Lateral Sclerosis Research (1 paper), Protein purification and stability (1 paper), Fatigue and fracture mechanics (1 paper) and Neurogenetic and Muscular Disorders Research (1 paper). The work is most often cited by research in Pharmaceutical Science (241 citations), Neurology (63 citations), Immunology (87 citations), Biomaterials (52 citations) and Microbiology (21 citations). Michael Hinchcliffe has collaborated with scholars based in United Kingdom, Norway and Italy. Frequent co-authors include Lisbeth Illum, Alan M. Smith, Alan Smith, Michael Perelman, Inderjit Jabbal‐Gill, Peter Watts, Abraham R. Tzafriri, H. Parnas, Yuhui Cheng and Richard Nankervis. Their work appears in journals such as Influenza and Other Respiratory Viruses, Clinical Cancer Research, Pharmaceutics, European Journal of Pharmaceutical Sciences and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.